Since 1995, 18 allogeneic haematopoietic stem cell transplantations were performed for seventeen cases with severe combined immunodeficiency (SCID). Fourteen donors were HLA-identical or one antigen mismatched sibling or parent. Three patients received CD34+ positive, CD3+ negatively selected , G-CSF mobilized haploidentical parental peripheral blood cell transplants. Of three patients, two (T-B-NK+) received Bu&Cy chemotherapy as conditioning. Bone marrow transplanted cases received 5-11x 108 / kg nucleated cells, while the CD34+ cell numbers were between 6-9x10 6/ kg in the peripheral blood samples. In all bone marrow transplanted patients T and B cell functions were evident by 3 weeks and 4 mo, respectively. However, a decline in immunoglobulin levels was observed in one patient two years after BMT. T cell development was slow in the haploidentical PB CD34+ selected transplants. The follow up period ranged between +20 days and 6 years ( median 8 mo). Main complications in the posttransplant period were disseminated BCG infection in 4, VOD in one, GVHD in one and worsening of pre-existing pneumonia in 2 patients. Five patients died because of pneumonia in 4, with unknown cause six months after transplantation in one. The presence of infection including disseminated BCG was the cause of major morbidity in the posttransplant course of this cohort.
